News & Events
Latest Blog Posts & Events
-
Study Identifies Hundreds of Cancer Drug TargetsThe study, which used data from NCI’s CPTAC, may fuel development of new cancer drugs.
-
DNA From an Ancient Virus Helps Many Cancers GrowResearchers have found the DNA fragment helps turn on cancer-related genes.
-
R15 Program: Growing the Cancer Research WorkforceThe grant program supports researchers, and their students, at smaller institutions.
Latest Press Releases
-
Immunotherapy approach shows potential in some people with metastatic solid tumors
A new cellular immunotherapy approach shrank tumors in 3 of 7 patients with metastatic colon cancer, in a small NCI clinical trial. Normal white blood cells from each patient were genetically engineered to produce receptors that recognize and attack their specific cancer cells.
-
For healthy adults, taking multivitamins daily is not associated with a lower risk of death
A large analysis of data from nearly 400,000 healthy U.S. adults followed for more than 20 years has found no association between regular multivitamin use and lower risk of death.
-
Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma
More than half of clinical trial participants treated with venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) had substantial tumor shrinkage. Of those, 38% had tumors that disappeared completely.
-
Inherited genetic factors may predict the pattern of X chromosome loss in older women
An NCI study explores the causes and effects of a phenomenon known as mosaic loss of chromosome X, or mLOX, which may lead to several health conditions, including cancer.
-
NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy
AI tool developed by NCI researchers uses routine clinical data, such as that from a simple blood test, to predict whether someone’s cancer will respond to immune checkpoint inhibitors, a type of immunotherapy.
Media Resources
Cancer Currents Blog
Find news and updates on the latest cancer research.